Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Use one compound at a time
Comparatively, tirzepatide, the active ingredient in Zepbound and Mounjaro, demonstrated an average weight loss of 22.9% at 176 weeks with the 15 mg dose in the SURMOUNT-1 Phase 3 study in adults with pre-diabetes and obesity or overweight
GLP-1 and weight loss injections also causes the body to digest food more slowly, which can further stave off hunger and result in increased satiety
Ozempic is primarily used for patients managing type 2 diabetes, although patients still see weight loss results
Metaxas C, Mathis D, Jeger C et al (2017) Early biomarker response and patient preferences to oral and intramuscular Vitamin B12 substitution in primary care: a randomized parallel-group trial
- Gas or bloating in sensitive individuals
US$ 24.78
US$ 20.71
US$ 24.81
